Insmed Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +54.4% | -33.3% | +94.2% | +30.8% | +22.8% | +7.3% | +56.2% | +33.2% | -19.7% | +52.3% | +11.8% | |
| – | +74.9% | -41.5% | +131.3% | +33.3% | +7.0% | +12.2% | +34.4% | +52.1% | -27.0% | +74.5% | +10.6% | |
| – | +77.7% | -42.5% | +134.4% | +29.9% | -1.5% | +9.3% | +34.5% | +49.8% | -55.1% | +15.1% | -8.0% | |
| – | +77.7% | -42.5% | +134.4% | +29.9% | -1.5% | +9.3% | +34.5% | +60.2% | -32.0% | +83.7% | -0.3% | |
| – | – | – | – | – | +248.7% | -13.9% | +47.0% | +22.0% | +38.6% | +26.3% | +170.8% | |
| – | – | – | – | – | +302.6% | +75.2% | +35.1% | +4.3% | +19.1% | +18.4% | +34.0% | |
| – | +7.4% | +23.8% | +24.1% | +82.1% | +165.9% | -10.3% | -1.8% | +6.7% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.8% | -8.5% | -8.2% | +176.3% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.8% | -8.5% | -8.2% | +49.8% | -6.8% | -7.3% | -7.9% | +66.5% | |
| – | +0.5% | +86.1% | +21.0% | +292.4% | +21.3% | +8.2% | +60.1% | +88.3% | +5.9% | +4.7% | -12.3% | |
| – | +13.4% | +25.7% | +59.5% | +78.5% | +6.9% | +39.4% | +13.8% | +40.7% | +18.6% | +31.9% | +57.6% | |
| – | -87.5% | +1,660.1% | +1.4% | – | – | +2.4% | -19.3% | -19.8% | +31.0% | +55.0% | +16.8% | |
| – | -19.3% | +39.8% | +40.5% | +20.9% | -25.7% | +225.0% | -16.5% | +41.0% | +29.6% | +11.7% | +9.4% | |
| – | -11.4% | +148.7% | +1.4% | +469.7% | +6.1% | +6.1% | +59.0% | +98.6% | +2.7% | -4.5% | -51.0% | |
| – | +67.4% | -50.4% | +133.7% | -42.3% | +25.6% | +5.4% | +48.8% | -78.6% | -477.4% | – | +158.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.1% | +5.6% | +7.6% | +15.5% | +10.0% | +15.4% | +14.9% | +9.7% | +14.1% | +16.8% | +30.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.